Saved source observation · CN3936165-A2

Imported Plasma and Recombinant Products

This is the latest observation of this contract, and the explorer’s totals use its value.

$169,523,999.00

Full reported contract value · AUD including applicable GST · 2023-01-01 to 2027-06-30

Reporting agency
National Blood Authority
Reported supplier
Novo Nordisk Pharmaceuticals Pty Ltd
Reported ABN
40 002 879 996. Exemption as supplied: No.
Category
Comprehensive health services
Procurement method
Limited tender
Original publication
2023-02-09 11:30:00 (ACT local time as supplied)
Amendment publication
2026-02-16 09:12:00 (ACT local time as supplied)
Amendment reason
Execution of option, extension, renewal, or other mechanism outlined when the contract was initially awarded
Agency reference
CBP-CON-00171
Approach to market / standing offer
ATM not supplied / Standing offer not supplied
Consultancy
No
Confidentiality as reported
Contract: No; outputs: No
Source observation
CN3936165-A2 · Official weekly workbook ending 2026-02-21 · sheet “Contract Notice Export”, row 1110.

The original register may now show later corrections. The card and this observation keep the saved source date.